Electroconvulsive Therapy Clinical Trial
Official title:
Cognitive Training for Memory Deficits Associated With Electroconvulsive Therapy
Verified date | July 2017 |
Source | New York State Psychiatric Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Although electroconvulsive therapy (ECT) remains the most effective treatment for people with severe depression, patients may experience a significant degree of persistent and/or permanent memory problems following ECT. Many patients report the memory problems are the most disturbing and serious side effect of ECT, and that such effects impact their quality of life following treatment and their willingness to consent to further ECT needed to complete a treatment course or to maintain remission. New developments in the field of cognitive remediation have demonstrated the benefits of cognitive training to improve memory performance in various conditions, such as epilepsy. However, these strategies have never been applied to help patients regain memory after ECT. The investigators have designed and piloted a novel cognitive program specifically targeted to the cognitive effects of ECT, based upon a program tailored to people with seizure disorders, a group with memory problems very similar to people who undergo ECT. This Memory Training for ECT (Mem-ECT) is designed to help cognitive functions that may be compromised following ECT remain relatively preserved. In addition, the intervention attempts to help ECT patients quickly regain their general memory skills immediately following ECT. Recent results from our preliminary group of patients who underwent ECT and memory training at New York Presbyterian shows no overall decline in memory function following ECT. On the basis of these promising findings, the investigators propose a more rigorous and larger study to confirm whether this novel memory training program can help alleviate memory problems associated with ECT.
Status | Completed |
Enrollment | 59 |
Est. completion date | May 2017 |
Est. primary completion date | August 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of Major Depressive Disorder - Inpatient at NYSPI or Presbyterian Hospital - Scheduled to undergo right-unilateral electroconvulsive therapy in the next two weeks - We do not require participants to be psychiatrically stable in terms of their symptoms. They only need to demonstrate capacity to consent and be willing to sit through 3 training sessions prior to ECT and 5 sessions post ECT Exclusion Criteria: - Significant auditory/visual impairment that would interfere with study procedures - Lack of aptitude in English that may interfere with the administration of the tests - Changes in the type of antidepressant during the course of ECT or 2 weeks post ECT - Chart diagnosis of any other medical or neuropsychiatric illnesses known to impair brain function (e.g. mental retardation, traumatic brain injury, schizophrenia) - History of ECT in past 2 months - Mental status examination score below 40/57 - Current substance abuse (e.g. marijuana or crack), excluding nicotine and caffeine. - Too agitated to sit through the required tests or training |
Country | Name | City | State |
---|---|---|---|
United States | New York State Psychiatric Institute | New York | New York |
Lead Sponsor | Collaborator |
---|---|
New York State Psychiatric Institute |
United States,
Choi J, Lisanby SH, Medalia A, Prudic J. A conceptual introduction to cognitive remediation for memory deficits associated with right unilateral electroconvulsive therapy. J ECT. 2011 Dec;27(4):286-91. doi: 10.1097/YCT.0b013e31821d3ab3. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Modified Mini-Mental State examination | 2 months after the last ECT session | ||
Primary | Columbia University Autobiographical Memory Interview-Short Form (AMI-SF) | 2 months after the last ECT session | ||
Secondary | Goldberg Remote Memory Questionnaire | 2 months after the last ECT session | ||
Secondary | Hamilton Rating Scale for Depression-24 item | 2 months after the last ECT session |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04348825 -
Electroconvulsive Therapy and Neuroradiology
|
||
Enrolling by invitation |
NCT05515159 -
Blood Biomarkers in Electroconvulsive Therapy
|
||
Completed |
NCT04022226 -
EEG Characteristics in ECT
|
Early Phase 1 | |
Recruiting |
NCT05889234 -
Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study
|
||
Recruiting |
NCT04291196 -
Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT
|
N/A | |
Recruiting |
NCT04160286 -
The Danish Neuropsychological Study of the Adverse Effects of ECT
|
||
Terminated |
NCT04383509 -
Electroconvulsive Treatment Followed by Cognitive Control Training
|
N/A | |
Completed |
NCT05683028 -
RCT for Electroconvulsive Treatment Followed by Cognitive Control Training
|
N/A | |
Completed |
NCT05633368 -
Impact of Covid-19 Pandemic on Patients Receiving Continuation or Maintenance Electroconvulsive Therapy
|
||
Completed |
NCT03359395 -
Pre-medication With Alfentanil vs Placebo During ECT
|
Phase 4 | |
Recruiting |
NCT05900245 -
Anesthesia Induction Schemes of Electroconvulsive Convulsions in Patients With Depression Based on EEG Monitoring
|
N/A | |
Recruiting |
NCT03542903 -
ECT in Ultra-resistant Schizophrenia
|
N/A | |
Completed |
NCT02819375 -
Comparison of Propofol, Propofol-remifentanil and Propofol-ketamine Anesthesia During Electroconvulsive Therapy
|
Phase 4 | |
Not yet recruiting |
NCT02305394 -
Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy
|
Phase 4 | |
Completed |
NCT02394847 -
Does Repetitive Electroconvulsive Therapies Affect Propofol Induction Dose ?
|
N/A | |
Recruiting |
NCT06109480 -
Effect of HD-tDCS Assisted ECT for Depression Disorder
|
N/A | |
Completed |
NCT05408000 -
Comparision of Motor Seizure Duration of Ketofol and Propofol for Electroconvulsive Therapy
|
N/A | |
Completed |
NCT01870219 -
Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy
|
Phase 4 | |
Completed |
NCT04028596 -
Measuring Blood Flow in the Brain After Epileptic Activity
|
Phase 2 | |
Completed |
NCT03113968 -
ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
|
Phase 2/Phase 3 |